Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
12.02 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -245.595 | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 | -29.497 | -42.854 | -67.982 | -9.531 | -7.616 | -6.058 |
| Depreciation & Amortization
| 7.098 | 6.266 | 5.373 | 1.145 | 0.426 | 0.33 | 0.2 | 0.169 | 0.045 | 0 | 0 | 0.009 |
| Deferred Income Tax
| 0 | 0 | 3.148 | 0.999 | -1.066 | -0.484 | 0.654 | 0.225 | 46.36 | 0 | 0 | 0.002 |
| Stock Based Compensation
| 39.406 | 31.009 | 29.237 | 18.567 | 13.371 | 13.601 | 4.036 | 2.909 | 2.38 | 0.177 | -0.148 | 0.486 |
| Change In Working Capital
| 13.458 | 6.076 | -3.386 | 15.029 | -3.726 | 4.385 | -2.027 | 2.123 | 0.669 | -1.474 | 0.736 | -1.588 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 9.674 | -4.827 | 11.015 | -2.722 | 5.89 | -1.141 | -0.041 | 0.487 | 0.917 | -0.158 | 0.159 |
| Other Working Capital
| 13.458 | -3.598 | 1.441 | 4.014 | -1.004 | -1.505 | -0.886 | 2.164 | 0.182 | -2.391 | 0.894 | -1.747 |
| Other Non Cash Items
| -9.283 | 0.37 | 13.534 | 29.32 | 3.602 | 2.898 | 0.522 | 0.162 | 1.112 | 1.085 | 0.573 | 0.213 |
| Operating Cash Flow
| -194.916 | -178.142 | -121.163 | -74.64 | -64.663 | -53.788 | -26.112 | -37.266 | -17.416 | -9.743 | -6.455 | -6.936 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -16.472 | -8.619 | -7.715 | -29.059 | -23.269 | -1.453 | -0.07 | -0.487 | -0.412 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 42.726 | 0.095 | 8.452 | 0.016 | 76.348 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -390.92 | -376.327 | -245.875 | -209.343 | -184.298 | -141.087 | -27.204 | -122.277 | -33.693 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 309.326 | 272.894 | 272.443 | 141.811 | 168.556 | 61.276 | 102.289 | 56.705 | 2.43 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -0.104 | -0.095 | -8.452 | -0.016 | -0.356 | 0 | 0 | 0 | 0 | 0 | 0.003 |
| Investing Cash Flow
| -98.066 | -69.326 | 18.853 | -96.591 | -39.011 | -5.272 | 75.015 | -66.059 | -31.675 | 0 | 0 | 0.003 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.738 | 13.359 | 0.56 | 7.915 | 2.5 |
| Common Stock Issued
| 208.394 | 155.335 | 37.681 | 281.354 | 178.104 | 154.022 | 0.035 | 3.997 | 112.05 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0.047 | 0 | -0.072 | 0 | -0.668 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.007 | 0 | 0 | 1.707 | -0.313 | 0.148 | 0.019 | 0.346 | 0.106 | 0.008 | 9.961 | 0 |
| Financing Cash Flow
| 208.401 | 155.288 | 0.038 | 282.989 | 177.791 | 153.502 | 0.025 | 0 | 125.515 | 0.568 | 17.876 | 2.5 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -84.581 | -92.18 | -64.629 | 111.758 | 74.117 | 94.442 | 48.922 | -50.244 | 76.424 | -9.175 | 11.421 | -4.433 |
| Cash At End Of Period
| 57.276 | 141.857 | 234.037 | 298.666 | 186.908 | 112.791 | 78.72 | 29.798 | 80.042 | 3.618 | 12.793 | 1.372 |